Progyny, Inc.
PGNY
$22.97
$0.120.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.24B | 1.21B | 1.17B | 1.14B | 1.13B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.24B | 1.21B | 1.17B | 1.14B | 1.13B |
| Cost of Revenue | 964.52M | 946.43M | 913.86M | 891.91M | 882.79M |
| Gross Profit | 277.44M | 266.75M | 253.36M | 246.83M | 250.21M |
| SG&A Expenses | 200.67M | 193.65M | 185.91M | 181.36M | 179.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.17B | 1.14B | 1.10B | 1.07B | 1.06B |
| Operating Income | 76.77M | 73.10M | 67.46M | 65.47M | 71.20M |
| Income Before Tax | 89.23M | 87.22M | 83.20M | 81.81M | 84.78M |
| Income Tax Expenses | 36.11M | 34.73M | 28.87M | 24.53M | 22.02M |
| Earnings from Continuing Operations | 53.12 | 52.50 | 54.34 | 57.27 | 62.75 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 53.12M | 52.50M | 54.34M | 57.27M | 62.75M |
| EBIT | 76.77M | 73.10M | 67.46M | 65.47M | 71.20M |
| EBITDA | 80.79M | 76.67M | 70.63M | 68.41M | 73.88M |
| EPS Basic | 0.61 | 0.59 | 0.59 | 0.61 | 0.66 |
| Normalized Basic EPS | 0.64 | 0.59 | 0.52 | 0.50 | 0.51 |
| EPS Diluted | 0.59 | 0.57 | 0.57 | 0.59 | 0.64 |
| Normalized Diluted EPS | 0.62 | 0.57 | 0.50 | 0.48 | 0.49 |
| Average Basic Shares Outstanding | 347.14M | 355.24M | 366.23M | 376.40M | 381.84M |
| Average Diluted Shares Outstanding | 361.68M | 369.88M | 381.63M | 393.46M | 400.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |